333 related articles for article (PubMed ID: 32671966)
21. COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm.
Lee W; Ahn JH; Park HH; Kim HN; Kim H; Yoo Y; Shin H; Hong KS; Jang JG; Park CG; Choi EY; Bae JS; Seo YK
Signal Transduct Target Ther; 2020 Sep; 5(1):186. PubMed ID: 32883951
[TBL] [Abstract][Full Text] [Related]
22. Elderly at time of COronaVIrus disease 2019 (COVID-19): possible role of immunosenescence and malnutrition.
Bencivenga L; Rengo G; Varricchi G
Geroscience; 2020 Aug; 42(4):1089-1092. PubMed ID: 32578073
[TBL] [Abstract][Full Text] [Related]
23. The "Three Italy" of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering complications other than pneumonia.
Prezioso C; Marcocci ME; Palamara AT; De Chiara G; Pietropaolo V
J Neurovirol; 2020 Jun; 26(3):311-323. PubMed ID: 32548750
[TBL] [Abstract][Full Text] [Related]
24. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".
Meftahi GH; Jangravi Z; Sahraei H; Bahari Z
Inflamm Res; 2020 Sep; 69(9):825-839. PubMed ID: 32529477
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19.
Wang L; Foer D; Bates DW; Boyce JA; Zhou L
J Allergy Clin Immunol; 2020 Oct; 146(4):808-812. PubMed ID: 32735807
[No Abstract] [Full Text] [Related]
26. Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients.
Xu ZS; Shu T; Kang L; Wu D; Zhou X; Liao BW; Sun XL; Zhou X; Wang YY
Signal Transduct Target Ther; 2020 Jun; 5(1):100. PubMed ID: 32561706
[No Abstract] [Full Text] [Related]
27. Tocilizumab for severe COVID-19: a systematic review and meta-analysis.
Lan SH; Lai CC; Huang HT; Chang SP; Lu LC; Hsueh PR
Int J Antimicrob Agents; 2020 Sep; 56(3):106103. PubMed ID: 32712333
[TBL] [Abstract][Full Text] [Related]
28. Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations.
Marzolini C; Stader F; Stoeckle M; Franzeck F; Egli A; Bassetti S; Hollinger A; Osthoff M; Weisser M; Gebhard CE; Baettig V; Geenen J; Khanna N; Tschudin-Sutter S; Mueller D; Hirsch HH; Battegay M; Sendi P
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32641296
[TBL] [Abstract][Full Text] [Related]
29. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
Costela-Ruiz VJ; Illescas-Montes R; Puerta-Puerta JM; Ruiz C; Melguizo-Rodríguez L
Cytokine Growth Factor Rev; 2020 Aug; 54():62-75. PubMed ID: 32513566
[TBL] [Abstract][Full Text] [Related]
31. Lessons from dermatology about inflammatory responses in Covid-19.
Criado PR; Pagliari C; Carneiro FRO; Quaresma JAS
Rev Med Virol; 2020 Sep; 30(5):e2130. PubMed ID: 32656939
[TBL] [Abstract][Full Text] [Related]
32. Development of child immunity in the context of COVID-19 pandemic.
Kloc M; Ghobrial RM; Kuchar E; Lewicki S; Kubiak JZ
Clin Immunol; 2020 Aug; 217():108510. PubMed ID: 32544611
[TBL] [Abstract][Full Text] [Related]
33. Critical COVID-19 disease, homeostasis, and the "surprise" of effective glucocorticoid therapy.
Chrousos GP; Meduri GU
Clin Immunol; 2020 Oct; 219():108550. PubMed ID: 32745524
[No Abstract] [Full Text] [Related]
34. A plea for the pathogenic role of immune complexes in severe Covid-19.
Vuitton DA; Vuitton L; Seillès E; Galanaud P
Clin Immunol; 2020 Aug; 217():108493. PubMed ID: 32526273
[No Abstract] [Full Text] [Related]
35. Accelerated T-Cell Immunosenescence in Cytomegalovirus-Seropositive Individuals After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Álvarez-Heredia P; Reina-Alfonso I; Domínguez-Del-Castillo JJ; Gutiérrez-González C; Hassouneh F; Batista-Duharte A; Pérez AB; Tarazona R; Solana R; Pera A
J Infect Dis; 2023 Aug; 228(5):576-585. PubMed ID: 37103009
[TBL] [Abstract][Full Text] [Related]
36. Is BCG vaccination affecting the spread and severity of COVID-19?
Ozdemir C; Kucuksezer UC; Tamay ZU
Allergy; 2020 Jul; 75(7):1824-1827. PubMed ID: 32330314
[No Abstract] [Full Text] [Related]
37. Aging immunity may exacerbate COVID-19.
Akbar AN; Gilroy DW
Science; 2020 Jul; 369(6501):256-257. PubMed ID: 32675364
[No Abstract] [Full Text] [Related]
38. COVID-19: In the Eye of the Cytokine Storm.
de la Rica R; Borges M; Gonzalez-Freire M
Front Immunol; 2020; 11():558898. PubMed ID: 33072097
[TBL] [Abstract][Full Text] [Related]
39. Infection risk of dermatologic therapeutics during the COVID-19 pandemic: an evidence-based recalibration.
Ghazawi FM; Lim M; Dutz JP; Kirchhof MG
Int J Dermatol; 2020 Sep; 59(9):1043-1056. PubMed ID: 32621284
[TBL] [Abstract][Full Text] [Related]
40. How the pandemic might play out in 2021 and beyond.
Scudellari M
Nature; 2020 Aug; 584(7819):22-25. PubMed ID: 32760050
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
